Index/Topics/Tirzepatide Compounding Regulation 2024-2025

Tirzepatide Compounding Regulation 2024-2025

Regulation and enforcement of tirzepatide compounding by FDA, involving Eli Lilly, and impacting pharmacies and clinics, with outcomes including lawsuits, recalls, and reputational risk.